Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Psychiatry
•
General Outpatient Psychiatry
•
Neuromodulation
•
Ketamine
What criteria do you use when deciding whether to start esketamine treatment for patients with treatment resistant MDD who are concomitant CNS depressants?
Related Questions
How do you determine the treatment course of esketamine or IV ketamine when used for treatment-resistant major depressive disorder?
How do you approach tapering electroconvulsive therapy after an acute treatment course leading to successful resolution of symptoms for treatment-resistant depression?
What is your experience with transcutaneous vagal nerve stimulation for treatment of anxiety disorders and major depressive disorder?
What strategies have you found most effective for supporting weight loss in patients with bipolar disorder while minimizing the risk of mood destabilization?
How can clinicians safely manage the potential cardiac risks associated with low-dose amphetamines in older adults, while ensuring the treatment's benefits outweigh the risks in cases of failure-to-thrive depression?
How do you approach pharmacologic management of OCD in patients with comorbid bipolar disorder, particularly when considering SSRIs or clomipramine?
What is your approach to the use of TMS for treatment refractory schizophrenia?
What pharmacologic treatments have you found helpful in treating comorbid schizophrenia and OCD?
How do you approach diagnosing ADHD in patients with significant trauma histories?
How do you manage lamotrigine or lithium induced acne?
